EGC Status. The Company qualifies as an emerging growth company, as defined in Section 2(a)(19) of the Securities Act, until no later than December 31, 2021.
Appears in 3 contracts
Samples: Open Market Sale (Selecta Biosciences Inc), Open Market Sale (Selecta Biosciences Inc), Sales Agreement (Selecta Biosciences Inc)
EGC Status. The Company qualifies as an emerging growth company, as defined in Section 2(a)(19) of the Securities Act, until no later than December 31, 2021.
Appears in 2 contracts
Samples: Open Market Sale (Selecta Biosciences Inc), Open Market Sale (Selecta Biosciences Inc)